12.86
price up icon1.98%   0.25
 
loading
前日終値:
$12.61
開ける:
$12.77
24時間の取引高:
70,975
Relative Volume:
0.38
時価総額:
$803.29M
収益:
-
当期純損益:
$-41.43M
株価収益率:
-16.28
EPS:
-0.79
ネットキャッシュフロー:
$-39.97M
1週間 パフォーマンス:
+6.90%
1か月 パフォーマンス:
+27.33%
6か月 パフォーマンス:
+58.57%
1年 パフォーマンス:
+5.07%
1日の値動き範囲:
Value
$12.59
$12.97
1週間の範囲:
Value
$10.96
$12.97
52週間の値動き範囲:
Value
$6.00
$20.50

Gh Research Plc Stock (GHRS) Company Profile

Name
名前
Gh Research Plc
Name
セクター
Healthcare (1168)
Name
電話
-
Name
住所
-
Name
職員
50
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
GHRS's Discussions on Twitter

GHRS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GHRS
Gh Research Plc
12.95 749.30M 0 -41.43M -39.97M -0.79
Biotechnology icon
ONC
Beone Medicines Ltd Adr
256.46 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
447.57 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2213 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
83.10 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
499.27 65.36B 14.09B 4.50B 2.96B 39.28

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-04 再開されました Cantor Fitzgerald Overweight
2025-03-13 開始されました Guggenheim Buy
2025-03-07 開始されました RBC Capital Mkts Outperform
2025-02-13 開始されました Cantor Fitzgerald Overweight
2022-08-16 開始されました H.C. Wainwright Buy
2022-06-16 開始されました ROTH Capital Buy
すべてを表示

Gh Research Plc (GHRS) 最新ニュース

pulisher
Jun 05, 2025

Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating - Insider Monkey

Jun 05, 2025
pulisher
Jun 05, 2025

GH Research (NASDAQ:GHRS) Now Covered by Cantor Fitzgerald - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

GHRS Stock Coverage Initiated with Positive Outlook | GHRS Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

cantor fitzgerald maintains overweight rating on gh research stock By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

cantor fitzgerald maintains overweight rating on gh research stock - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Takes $44,000 Position in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

How To Trade (GHRS) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 02, 2025

Northern Trust Corp Has $286,000 Holdings in GH Research PLC (NASDAQ:GHRS) - Defense World

Jun 02, 2025
pulisher
May 27, 2025

GH Research to Present at ASCP Meeting on Breakthrough Depression Treatment - TipRanks

May 27, 2025
pulisher
May 22, 2025

(GHRS) Long Term Investment Analysis - news.stocktradersdaily.com

May 22, 2025
pulisher
May 21, 2025

GH Research to Present at ASCP Meeting on Depression Treatments - TipRanks

May 21, 2025
pulisher
May 21, 2025

GH Research PLC (NASDAQ:GHRS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

May 21, 2025
pulisher
May 20, 2025

Beckley’s psychedelic reduces depression - BioWorld MedTech

May 20, 2025
pulisher
May 16, 2025

GH Research (NASDAQ:GHRS) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Confe - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research (GHRS) Highlights Phase 2b Results at Clinical Conference | GHRS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

GH Research Showcases Promising Depression Treatment Data at ASCP Meeting - TipRanks

May 15, 2025
pulisher
May 15, 2025

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting - Yahoo

May 15, 2025
pulisher
May 12, 2025

GH Research’s (GHRS) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 12, 2025
pulisher
May 12, 2025

Guggenheim Cuts GH Research (NASDAQ:GHRS) Price Target to $29.00 - Defense World

May 12, 2025
pulisher
May 10, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 10, 2025

GHRS Stock: HC Wainwright & Co. Reiterates Buy Rating | GHRS Sto - GuruFocus

May 10, 2025
pulisher
May 09, 2025

GH Research: Promising Clinical Results and Strong Financial Position Justify Buy Rating - TipRanks

May 09, 2025
pulisher
May 09, 2025

GH Research (GHRS) Price Target Lowered by Guggenheim | GHRS Stock News - GuruFocus

May 09, 2025
pulisher
May 08, 2025

GH Research PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

GHRS Reports Strong Financial Position with Increased Cash Holdi - GuruFocus

May 08, 2025
pulisher
May 08, 2025

GH Research Reports Q1 2025 Financial Results Amidst Ongoing Challenges - TipRanks

May 08, 2025
pulisher
May 08, 2025

GH Research PLC Reports Positive Phase 2b Trial Results for GH001 in Treatment-Resistant Depression and Financial Update for Q1 2025 - Nasdaq

May 08, 2025
pulisher
May 08, 2025

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Stock Titan

May 08, 2025
pulisher
May 05, 2025

What Makes GH Research (GHRS) a New Buy Stock - Yahoo Finance

May 05, 2025
pulisher
May 01, 2025

Where are the Opportunities in (GHRS) - news.stocktradersdaily.com

May 01, 2025
pulisher
May 01, 2025

Hims & Hers Health (NYSE:HIMS) Shares Down 8.3% Following Insider Selling - American Banking and Market News

May 01, 2025
pulisher
Apr 21, 2025

Legal & General Group Plc Sells 18,302 Shares of Guardant Health, Inc. (NASDAQ:GH) - Defense World

Apr 21, 2025
pulisher
Apr 18, 2025

What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister

Apr 18, 2025
pulisher
Apr 16, 2025

Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine

Apr 16, 2025
pulisher
Apr 16, 2025

(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Mar 31, 2025

(GHRS) Proactive Strategies - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 20, 2025

JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 13, 2025

Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Mar 13, 2025
pulisher
Mar 11, 2025

GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater

Mar 11, 2025
pulisher
Mar 10, 2025

How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com

Mar 10, 2025
pulisher
Mar 10, 2025

GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

GH Research PLC (NASDAQ:GHRS) Receives $30.67 Consensus PT from Brokerages - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Q1 Earnings Forecast for GH Research Issued By HC Wainwright - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

RBC Capital Initiates Coverage of GH Research (GHRS) with Outperform Recommendation - Nasdaq

Mar 07, 2025
pulisher
Mar 07, 2025

FY2029 EPS Estimates for GH Research Lifted by HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

GH Research initiated with an Outperform at RBC Capital - TipRanks

Mar 07, 2025
pulisher
Mar 05, 2025

GH Research PLC Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

H.C. Wainwright maintains $40 target on GH Research stock - Investing.com

Mar 05, 2025

Gh Research Plc (GHRS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price up icon 1.30%
$584.68
price up icon 0.75%
$308.75
price up icon 1.19%
$37.33
price up icon 2.30%
$4.68
price down icon 3.35%
$492.00
price up icon 1.78%
大文字化:     |  ボリューム (24 時間):